They have $3B of ad spend flowing through Symphony product, estimated to grow this to $7B in next 2-3 years after GroupM announcement. The key is to get some of this ad spend through Symphony into its Forward Automatic Guaranteed marketplace (the integration is complete as far as I know with some improvements being worked on). This is a new market estimated at $8B atm but growing strongly.
They make between 5%-15% for every dollar in this segment (Trading segment). So if they even got 5% of the $7B and we take the low commission rate of 5%, that still equals $17,500,000 per year in revenue + increasing license fees for Symphony product (these are fixed fees based on regions etc), say approx $10,000,000 = $27,500,000 per annum on very conservative figures
Need traction in the flow of dollars into Trading Segment, once a sniff of this occurs then market should react strongly.
$4.5M +$2.5M in R and D refund buys us a few quarters.
- Forums
- ASX - By Stock
- ADJ - Looking for a new leg up
They have $3B of ad spend flowing through Symphony product,...
Featured News
Add ADS (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.042M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ADS (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online